1. Home
  2. TEX vs KNSA Comparison

TEX vs KNSA Comparison

Compare TEX & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terex Corporation

TEX

Terex Corporation

HOLD

Current Price

$68.13

Market Cap

6.7B

Sector

Industrials

ML Signal

HOLD

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$45.96

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEX
KNSA
Founded
1933
2015
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
3.4B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
TEX
KNSA
Price
$68.13
$45.96
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$66.67
$55.29
AVG Volume (30 Days)
2.3M
515.3K
Earning Date
05-12-2026
05-18-2026
Dividend Yield
1.02%
N/A
EPS Growth
N/A
225.00
EPS
3.33
0.75
Revenue
$5,421,000,000.00
$677,564,000.00
Revenue This Year
$47.78
$35.71
Revenue Next Year
$7.13
$17.13
P/E Ratio
$20.13
$60.26
Revenue Growth
5.73
60.09
52 Week Low
$31.53
$18.26
52 Week High
$71.50
$49.12

Technical Indicators

Market Signals
Indicator
TEX
KNSA
Relative Strength Index (RSI) 57.58 56.88
Support Level $48.89 $40.47
Resistance Level $71.50 $49.12
Average True Range (ATR) 2.94 2.08
MACD -0.32 -0.08
Stochastic Oscillator 60.89 62.25

Price Performance

Historical Comparison
TEX
KNSA

About TEX Terex Corporation

Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Share on Social Networks: